- Home
- ENGN vs WTBA Comparison
ENGN vs WTBA Comparison
Compare ENGN & WTBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | ENGN | WTBA |
|---|---|---|
| Founded | 1999 | 1893 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Major Banks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.2M | 488.6M |
| IPO Year | 2023 | 2002 |
Fundamental Metrics
Financial Performance| Metric | ENGN | WTBA |
|---|---|---|
| Price | $1.94 | $29.00 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | $21.08 | ★ $24.00 |
| AVG Volume (30 Days) | ★ 660.1K | 36.1K |
| Earning Date | 06-11-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 4.17% |
| EPS Growth | ★ 56.85 | 35.21 |
| EPS | N/A | ★ 1.26 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $23.80 |
| Revenue Next Year | N/A | $9.39 |
| P/E Ratio | ★ N/A | $22.63 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.40 | $19.03 |
| 52 Week High | $12.25 | $30.33 |
Technical Indicators
Market Signals| Indicator | ENGN | WTBA |
|---|---|---|
| Relative Strength Index (RSI) | 58.14 | 44.59 |
| Support Level | $1.67 | $27.54 |
| Resistance Level | $7.92 | $28.80 |
| Average True Range (ATR) | 0.07 | 0.52 |
| MACD | 0.02 | -0.08 |
| Stochastic Oscillator | 68.75 | 4.12 |
Price Performance
Historical ComparisonAbout ENGN enGene Holdings Inc.
enGene Therapeutics Inc is a clinical-stage biotechnology company mainstreaming gene therapy through the delivery of therapeutics to mucosal tissues and other organs, to create new ways to address diseases with high clinical needs. Its pioneering program is detalimogene voraplasmid (also known as detalimogene) for patients with Non-Muscle Invasive Bladder Cancer (NMIBC), a disease with a high clinical burden. Detalimogene is being evaluated in the ongoing multi-cohort LEGEND Phase 2 trial, which includes a pivotal cohort studying detalimogene in high-risk, Bacillus Calmette-Guerin (BCG)-unresponsive patients with carcinoma in situ (CIS) with or without concomitant papillary disease. It is developed using enGene's proprietary Dually Derivatized Oligochitosan (DDX) platform.
About WTBA West Bancorporation
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings, and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America.